Routinely Obtained Diagnostic Material as a Source of RNA for Personalized Medicine in Lung Cancer Patients

Routinely processed clinical diagnostic samples provide a suitable source of RNA for polymerase chain reaction-based molecular analyses, potentially providing personalized medicine to all lung cancer patients.